Adalimumab
CAS: 331731-18-1
Ref. 3D-FI139131
1mg | 711.00 € | ||
2mg | 863.00 € | ||
5mg | 1,276.00 € | ||
10mg | 2,261.00 € | ||
25mg | 4,347.00 € |
Product Information
- Immunoglobulin G1
- disulfide with human monoclonal D2E7 light chain dimer
- D 2E7
- Humira
- Unii-fys6T7F842
Adalimumab is a monoclonal antibody that binds to TNF-α, a proinflammatory cytokine. It is used in the treatment of inflammatory bowel disease and other autoimmune diseases. Adalimumab has been shown to be effective in clinical trials of patients with Crohn's disease and ulcerative colitis. This is research biosimilar for R&D use only.
Chemical properties
Technical inquiry about: 3D-FI139131 Adalimumab
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.